Weekly Commentary | March 13, 2022

We are remaining patient here for additional purchases for now.  The rise in leverage costs are just starting to hit fund earnings which means distribution cuts are coming.  Assets are cheaper but not a screaming buy by any means.  And discounts are cheapening finally in taxable bond funds but they are also not a pound the table buy.

Macro Commentary

For …